DOCSLIB.ORG

A Time-Release History of the Opioid Epidemic Springerbriefs in Molecular Science

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Time-Release History of the Opioid Epidemic Springerbriefs in Molecular Science SPRINGER BRIEFS IN MOLECULAR SCIENCE HISTORY OF CHEMISTRY J. N. Campbell · Steven M. Rooney A Time-Release History of the Opioid Epidemic SpringerBriefs in Molecular Science History of Chemistry Series editor Seth C. Rasmussen, Department of Chemistry and Biochemistry, North Dakota State University, Fargo, ND, USA More information about this series at http://www.springer.com/series/10127 J. N. Campbell • Steven M. Rooney A Time-Release History of the Opioid Epidemic 123 J. N. Campbell Steven M. Rooney Independent Scholar Independent Scholar Spring, TX, USA Irving, TX, USA ISSN 2191-5407 ISSN 2191-5415 (electronic) SpringerBriefs in Molecular Science ISSN 2212-991X SpringerBriefs in History of Chemistry ISBN 978-3-319-91787-0 ISBN 978-3-319-91788-7 (eBook) https://doi.org/10.1007/978-3-319-91788-7 Library of Congress Control Number: 2018941231 © The Author(s) 2018 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by the registered company Springer International Publishing AG part of Springer Nature The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland Though bitter, good medicine cures illness. Though it may hurt, loyal criticism will have beneficial effects. —Sima Qian, Han Chinese Historian (c. 145–86 BCE) For Nik and her elegant deductions Preface History, Stephen said, is a nightmare from which I am trying to awake. —James Joyce, Ulysses, 1922 [1] Many a comic book poses the question: what if you could go back in time and find the exact point where some major catastrophe originated, could you make a dif- ference by altering it? Marvel’s Days of Future Past or DC’s Flashpoint Paradox serve as examples of what we create for ourselves when we go back in history and change something in order to suit our own needs. Would it make a difference? These scenarios present a conundrum for those perceived to be so powerful because, as the theoretical physics goes, if you change one thing, you change everything. These stories are like the search to be modern; something that seems like a great plan, but questions abound. What other ripples does it generate when we devote ourselves to all the wonderful promises and innovations that come with it? Then, we might ask: Where in the long history did opioids and their influence go wrong? In the media, we hear regularly that America is in the midst of a recent crisis because, since the 1990s, big pharmaceutical companies, distributors, and even drugstore chains are pumping out too many of these products. Doctors are also complicit as their over-prescription has driven people from all walks of life to addiction. The government remains powerless even though it has legislated on similar issues for over a century. In addendum, what of the academic departments in biochemistry, chemistry, physiology, and in the medical schools of the country, are they complicit? As this brief will argue, it is not one person, one entity’s fault, one type opioid, per se, and there is no one point in history where all this devolved. The modern fully synthetic opioid possesses a literal time-release capability as it enters the body; but, these drugs, which have always exercised power once ingested, also have had the same effect historically. That is, their evolution, slowly, carefully, and frequently subtly, has also unfolded progressively over time. To put it another way, the current crisis when examined from a broader set of historical evidence over a wide expanse of time, assists us with understanding how the USA arrived at such a crossroads. What a macro-approach in this monograph posits is that we can deliver ix x Preface perspective by returning to the beginning, which will assist in adequately tracing the origins of this paradox of pain relief. The chemical story or treatment, if you will, behind these drugs that we examine in A Time-Release History of the Opioid Epidemic is dedicated to the chemists and the staffs in the laboratories that were trying to solve an age-old issue—relieving pain. We have heard through news agencies, doctors, and other specialists that opioids are the root of all sorts of social maladies and that a culture war in America is raging: The employed becoming unemployed, slowly destroying neighborhoods, wrecking families; and yet, they have become central to mainstream healthcare delivery for those seeking pain relief. The media has done much to publicize and demonize the numbing (a term used in the nineteenth century) opioid effect. However, we have seen little in the way of scholarship from the chemical com- munity to try and explain its origins; other than highlighting parts of its history and relating stories of addiction which do little except to frighten us with tales of misery and woe. If this truly is an epidemic, then we as a collective must seek to under- stand the causes of this crisis in both the distant and the recent past. Spring, TX, USA J. N. Campbell Irving, TX, USA Steven M. Rooney Reference 1. Joyce J (1986) Ulysses, 1st edn. Vintage, New York, p 158 Acknowledgements In our last brief, How Aspirin Entered Our Medicine Cabinet, we set out to produce a highly readable piece of scholarship that drew not only from chemistry and science, but a variety of fields that engaged socioeconomic history, ethnography, psychology, material thought and culture, and architecture and the built environ- ment. What we found at the center of this modern story was a complex synthetic medicine that was born during the Industrial Revolution and accelerated in usage during the period of the Great War. Repeatedly, nations across the West turned to aspirin to solve maladies that they did not understand. They blundered through extreme body counts racked up by bullets and a Great Pandemic that produced unintended consequences. After so much destruction and conflict at the end of the Second World War, a host of chemists, doctors, pharmacists, drug companies, government entities, and advertising firms combined to wage what became known as the “aspirin wars” during the 1950s through the 1970s. Though American society evolved and matured, digressed and faltered, aspirin's chemistry remained. In its purest form, aspirin was just that, aspirin. Nevertheless, it was far from just another member of the medicine cabinet. Thus, its chemical construct stood silently waiting while trials and cause/effect attempted to liberate its secrets. The innovations in the chemistry laboratory were integral in making aspirin a wonder drug, but it took those studies and manipulations to solve the riddle of things like heart attacks and strokes. Aspirin was, once the correct dosage tested in trials by scientists and doctors alike over successive generations, a drug that could enter mainstream use, without debate over how it could be harmful. Our next brief, A Time-Release History of the Opioid Epidemic runs along a much different arc than aspirin. It seems to be the anti-aspirin, so to speak. To put it another way, if aspirin could be billed as the utopia, then opioids appear to range into the realm of something dystopian, especially when abused. This brief in long-form, spotlights what has been described by the media and the federal government as an opioid epidemic. In 2018, the USA is embroiled in a highly emotional and volatile situation that is tearing families and communities apart. As historians of science, our task is to enliven chemistry by interpreting the past. Inspired by science and xi xii Acknowledgements technology studies (STS), we acknowledge that politics and social concerns cloud current discussions about history and create anachronisms. The opiates of the nineteenth century are not the opioids of today; however, their ecological devel- opment and influence are inextricably linked to their subsequent descendants. Over the past 200-plus years, claims of the arrival of a panacea occurred in a cyclical fashion. What we can do is analyze those patterns is explore the origins of these drugs in order to figure out what role the chemistry laboratory has played in the making of such a horrendous situation. The lab holds the key moving forward. Part science and social process, our story pertains to humanity; after all, it is individuals who built the laboratory and produced the opioids that emerged from it. While on the subject of humans, we want to extend our gratitude to several significant people who have inspired, read, and commented on our work. They include: Michael Wintroub and Helen Mialet, whose scholarship concerning heterotopias and ethnographic approaches to all kinds of laboratories has been seminal to our thinking.
Load more

Recommended publications
  • Pain-Relievers
    Pain-Relievers Pain. It is a common experience though the cause Ibuprofen/Naproxen and severity differ greatly. Lucky for us there are pain-relievers (analgesics). Purpose: To reduce inflammation, reduce pain (E.g. Headache, mild or moderate pain. More Which pain- effective than aspirin or reliever will be acetaminophen for relief the most menstrual cramps effective one (dysmenorrhea). for you? Adverse Reactions: Commonly used nausea, heartburn, pain relievers diarrhea, indigestion, are not only abdominal discomfort, used for mild bleeding and ulcers. pain but also fever reduction and inflammation. Choose your pain reliever wisely for the most Examples: Advil, Motrin, Nuprin, Metaprin. effective treatment possible. The following Aleve and naproxen are similar to ibuprofen, information will give you a brief outline for each but last longer. All must be taken with food. commonly used pain relieving substance. Not recommended for use by pregnant or There are generic forms of each of the pain breast-feeding women. relievers. The generic pain relievers are as effective as the “Name Brand” pain relievers, and Avoid if any history of aspirin sensitivity. cost considerably less. For more information ask your pharmacist or health practitioner. Acetaminophen Aspirin Purpose: reduce pain, reduce fever Purpose: To reduce inflammation, pain, fever, (E.g. headache, and low intensity pain (E.g. headache, joint fever) pain, muscle pain) Adverse Adverse Reactions: skin rash, hives, shortness Reactions: of breath, asthma, shock, edema (swelling), Stomach irritation, stomach irritation, bleeding and ulcers. skin rash much less common than with Examples: Bayer aspirin. Aspirin, Bayer Timed Release, generic Examples: Tylenol, Panadol, Aspirin Free, aspirin. Anacin and Apap.
    [Show full text]
  • Synthesis of Aspirin
    SYNTHESIS OF ASPIRIN I. OBJECTIVES AND BACKGROUND You will: synthesize acetylsalicylic acid (aspirin) by carrying out a simple organic reaction, separate your product from the reaction mixture by vacuum filtration, purify your product by recrystallization, perform a chemical test to identify the change in functional group from reactant to product, and determine the success of your synthesis by calculating the percentage yield of your product. INTRODUCTION Aspirin is one of the most widely used medications in the world. It is employed as an analgesic (pain relief), an anti-pyretic (fever control) and an anti-inflammatory. More recently, studies have indicated that daily intake of small doses of aspirin can lower the risk of heart attack and stroke in high-risk patients. The history of aspirin and its precursor dates back to ancient times. Documents attributed to Hippocrates, the father of modern medicine, from the 4th century B.C. refer to the alleviation of pain by chewing on the bark of a willow tree or ingesting a powder made from the bark and leaves of the willow. This remedy was passed on from generation to generation. Fast forward now to the 19th century, where the field of organic chemistry began to experience tremendous growth. By 1838, chemists had managed to isolate, purify and identify the component of willow bark that provided the analgesic benefit. The compound was named salicylic acid, which was based on the genus name of the willow. Efforts to market salicylic acid met with failure, due to an unfortunate side effect-- prolonged ingestion of salicylic acid led to stomach pain, and in some cases, ulcers.
    [Show full text]
  • Attenuated Total Reflection Infrared Spectroscopy (ATR-IR) As an in Situ Technique for Dissolution Studies Abe S
    Seton Hall University eRepository @ Seton Hall Seton Hall University Dissertations and Theses Seton Hall University Dissertations and Theses (ETDs) Summer 8-2011 Attenuated Total Reflection Infrared Spectroscopy (ATR-IR) as an In Situ Technique for Dissolution Studies Abe S. Kassis Seton Hall University Follow this and additional works at: https://scholarship.shu.edu/dissertations Part of the Biochemistry Commons Recommended Citation Kassis, Abe S., "Attenuated Total Reflection Infrared Spectroscopy (ATR-IR) as an In Situ Technique for Dissolution Studies" (2011). Seton Hall University Dissertations and Theses (ETDs). 1432. https://scholarship.shu.edu/dissertations/1432 Attenuated Total Reflection Infrared Spectroscopy (ATR-IR) as an In Situ Technique for Dissolution Studies by Abe S. Kassis Ph.D. DISSERTATION Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Chemistry and Biochemistry of Seton Hall University Seton Hall University Department of Chemistry and Biochemistry 400 South Orange Avenue South Orange, New Jersey 07079 August 2011 DISSERTATION COMMITTEE APPROVALS We certify that we have read this thesis and that in our opinion it is sufficient in scientific scope and quality as a dissertation for the degree of Doctor of Philosophy APPROVED BY: Advisor, Seton Hall University Nicholas H. Snow, Ph.D. Member of Dissertation Committee, Seton Hall University Tarun ~el, Ph.D. Member of Dissertation Committee, Novartis Pharmaceuticals Corporation Q\A"b A lM~ en P. KeI;y, Ph.D. Chair, Department ofChemistry and Biochemistry, Seton Hall University [ii] "Although nature commences with reason and ends in experience it is necessary for us to do the opposite, that is to commence with experience and from this to proceed to investigate the reason." -Leonardo da Vinci [iii] Abstract Attenuated Total Reflection Infrared Spectroscopy (ATR-IR) as an in situ Technique for Dissolution Studies Dissolution studies are critical tests for measuring the performance, or rate of release, of a drug product.
    [Show full text]
  • A History of Aspirin
    Physicians, Fads, and Pharmaceuticals: A History of Aspirin Anne Adina Judith Andermann*, B.Sc., M.Phil. Cantab * To whom correspondence should be addressed: Faculty of Medicine, McGill University, 3655 Drummond St., Montreal, QC, Canada H3G 1Y6"Politics is not out there in society. Politics is down there in the laboratory." --Bruno Latour (1). Aspirin is a product of the late-nineteenth-century laboratory, pharmaceutical industry, and medical community. The prevailing scientific techniques, industrial approaches, and medical beliefs were instrumental in the development, promotion and reception of the drug. As a result, the present account does not extend further back than a few decades prior to the release of aspirin from the laboratories of Farbenfabriken vormals Friedrich Bayer & Co. in 1899. In contrast, much of the current literature on aspirin (2,3,4) attempts to trace the compound back to antiquity through the Ebers papyrus, the Hippocratic writings, and the works of Galen. Such histories tell a simple, linear tale of the numerous "discoveries" proposed to have led to the use of certain salicylate-containing plants, such as willow bark and wintergreen, or salicylate-related compounds, including salicilin and salicylic acid, as cures for a variety of ailments. Indeed, according to Mann and Plummer: Both [salicilin and salicylic acid] attacked fever and pain, and their partisans advocated the salicylates' use as antiseptics, mouthwashes, and water preservatives for ocean voyages; one important chemist further suggested (erroneously) that sodium salicylate, a chemical relative, would successfully treat scarlet fever, diphtheria, measles, syphilis, cholera, rabies and anthrax (5). However, it is difficult to establish what effect, if any, these examples of the "historical" uses of "proto-aspirin" had on the impetus for and modes of developing and using the actual drug called aspirin.
    [Show full text]
  • Cumulated Bibliography of Biographies of Ocean Scientists Deborah Day, Scripps Institution of Oceanography Archives Revised December 3, 2001
    Cumulated Bibliography of Biographies of Ocean Scientists Deborah Day, Scripps Institution of Oceanography Archives Revised December 3, 2001. Preface This bibliography attempts to list all substantial autobiographies, biographies, festschrifts and obituaries of prominent oceanographers, marine biologists, fisheries scientists, and other scientists who worked in the marine environment published in journals and books after 1922, the publication date of Herdman’s Founders of Oceanography. The bibliography does not include newspaper obituaries, government documents, or citations to brief entries in general biographical sources. Items are listed alphabetically by author, and then chronologically by date of publication under a legend that includes the full name of the individual, his/her date of birth in European style(day, month in roman numeral, year), followed by his/her place of birth, then his date of death and place of death. Entries are in author-editor style following the Chicago Manual of Style (Chicago and London: University of Chicago Press, 14th ed., 1993). Citations are annotated to list the language if it is not obvious from the text. Annotations will also indicate if the citation includes a list of the scientist’s papers, if there is a relationship between the author of the citation and the scientist, or if the citation is written for a particular audience. This bibliography of biographies of scientists of the sea is based on Jacqueline Carpine-Lancre’s bibliography of biographies first published annually beginning with issue 4 of the History of Oceanography Newsletter (September 1992). It was supplemented by a bibliography maintained by Eric L. Mills and citations in the biographical files of the Archives of the Scripps Institution of Oceanography, UCSD.
    [Show full text]
  • Design and Synthesis of Functionally Selective Kappa Opioid Receptor Ligands
    Design and Synthesis of Functionally Selective Kappa Opioid Receptor Ligands By Stephanie Nicole Johnson Submitted to the graduate degree program in Medicinal Chemistry and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Masters in Science. Chairperson: Dr. Thomas E. Prisinzano Dr. Apurba Dutta Dr. Jeffrey P. Krise Date Defended: May 2, 2017 The Thesis Committee for Stephanie Nicole Johnson certifies that this is the approved version of the following thesis: Design and Synthesis of Functionally Selective Kappa Opioid Receptor Ligands Chairperson: Dr. Thomas E. Prisinzano Date approved: May 4, 2017 ii Abstract The ability of ligands to differentially regulate the activity of signaling pathways coupled to a receptor potentially enables researchers to optimize therapeutically relevant efficacies, while minimizing activity at pathways that lead to adverse effects. Recent studies have demonstrated the functional selectivity of kappa opioid receptor (KOR) ligands acting at KOR expressed by rat peripheral pain sensing neurons. In addition, KOR signaling leading to antinociception and dysphoria occur via different pathways. Based on this information, it can be hypothesized that a functionally selective KOR agonist would allow researchers to optimize signaling pathways leading to antinociception while simultaneously minimizing activity towards pathways that result in dysphoria. In this study, our goal was to alter the structure of U50,488 such that efficacy was maintained for signaling pathways important for antinociception (inhibition of cAMP accumulation) and minimized for signaling pathways that reduce antinociception. Thus, several compounds based on the U50,488 scaffold were designed, synthesized, and evaluated at KORs. Selected analogues were further evaluated for inhibition of cAMP accumulation, activation of extracellular signal-regulated kinase (ERK), and inhibition of calcitonin gene- related peptide release (CGRP).
    [Show full text]
  • Former Fellows Biographical Index Part
    Former Fellows of The Royal Society of Edinburgh 1783 – 2002 Biographical Index Part Two ISBN 0 902198 84 X Published July 2006 © The Royal Society of Edinburgh 22-26 George Street, Edinburgh, EH2 2PQ BIOGRAPHICAL INDEX OF FORMER FELLOWS OF THE ROYAL SOCIETY OF EDINBURGH 1783 – 2002 PART II K-Z C D Waterston and A Macmillan Shearer This is a print-out of the biographical index of over 4000 former Fellows of the Royal Society of Edinburgh as held on the Society’s computer system in October 2005. It lists former Fellows from the foundation of the Society in 1783 to October 2002. Most are deceased Fellows up to and including the list given in the RSE Directory 2003 (Session 2002-3) but some former Fellows who left the Society by resignation or were removed from the roll are still living. HISTORY OF THE PROJECT Information on the Fellowship has been kept by the Society in many ways – unpublished sources include Council and Committee Minutes, Card Indices, and correspondence; published sources such as Transactions, Proceedings, Year Books, Billets, Candidates Lists, etc. All have been examined by the compilers, who have found the Minutes, particularly Committee Minutes, to be of variable quality, and it is to be regretted that the Society’s holdings of published billets and candidates lists are incomplete. The late Professor Neil Campbell prepared from these sources a loose-leaf list of some 1500 Ordinary Fellows elected during the Society’s first hundred years. He listed name and forenames, title where applicable and national honours, profession or discipline, position held, some information on membership of the other societies, dates of birth, election to the Society and death or resignation from the Society and reference to a printed biography.
    [Show full text]
  • A Global Review on Short Peptides: Frontiers and Perspectives †
    molecules Review A Global Review on Short Peptides: Frontiers and Perspectives † Vasso Apostolopoulos 1 , Joanna Bojarska 2,* , Tsun-Thai Chai 3 , Sherif Elnagdy 4 , Krzysztof Kaczmarek 5 , John Matsoukas 1,6,7, Roger New 8,9, Keykavous Parang 10 , Octavio Paredes Lopez 11 , Hamideh Parhiz 12, Conrad O. Perera 13, Monica Pickholz 14,15, Milan Remko 16, Michele Saviano 17, Mariusz Skwarczynski 18, Yefeng Tang 19, Wojciech M. Wolf 2,*, Taku Yoshiya 20 , Janusz Zabrocki 5, Piotr Zielenkiewicz 21,22 , Maha AlKhazindar 4 , Vanessa Barriga 1, Konstantinos Kelaidonis 6, Elham Mousavinezhad Sarasia 9 and Istvan Toth 18,23,24 1 Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia; [email protected] (V.A.); [email protected] (J.M.); [email protected] (V.B.) 2 Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego˙ 116, 90-924 Lodz, Poland 3 Department of Chemical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia; [email protected] 4 Botany and Microbiology Department, Faculty of Science, Cairo University, Gamaa St., Giza 12613, Egypt; [email protected] (S.E.); [email protected] (M.A.) 5 Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego˙ 116, 90-924 Lodz, Poland; [email protected] (K.K.); [email protected] (J.Z.) 6 NewDrug, Patras Science Park, 26500 Patras, Greece; [email protected] 7 Department of Physiology and Pharmacology,
    [Show full text]
  • The Development of the Chlorinity-Salinity Concept in Oceanography
    AN ABSTRACT OF THE THESIS OF WILLIAM JOHN WALLACE, JR. for the Ph. D. (Name) (Degree) in GENERAL SCIENCE presented on April 7,1971 (Major) (Date) Title: THE DEVELOPMENT OF THE CHLORINITY-SALINITY CONCEPT INOCEANOGRAM Redacted for Privacy Abstract approved: Vert J. Moris This study traces the historical foundations of the concept of constant ionic proportionality and the equation (Salinity[S°700] = 1.805 Chlorinity [C1700] + 0.030) which has been in general use in ocean- ography since 1902 until 1969 and which is based upon this constancy, The notion that the constituents present in sea water exist in constant proportions was first clearly stated by Marcet in 1819.The germ of the idea may be found, however, in the worksof Bergmann in the late eighteenth century and implied in other works.Maury, in the mid-nineteenth century, popularized the concept and Forchhammer, in 1865, strengthened this idea by quantifying it and introducing the use of the "coefficient" of chlorine to determine salinity,Although he determined a slightly different value for the coefficient, Dittmar regarded his analysis of the sea water samples from the Challenger expedition as a vindication of Forchhammer's work.Knudsen, Forch and Sorensen, in 1902 gave a lengthy gravimetric definition for salinity based on the analysis of nine water samples.As this proce- dural definition was in practice too time-consuming to perform, the above equation was presented which relates the determination of salinity to that of chlorinity.The work of Knudsen, Forch and Sorensen, and that of Dittmar before them, wasaccepted as demonstrating the constancy of ionic proportionality, and the equation was a cornerstone of chemical oceanographyfrom 1902 to 1958.
    [Show full text]
  • ESI-MS Method for the Simultaneous Detection of Five Major Opium Alkaloids
    Development and evaluation of an LC- ESI-MS method for the simultaneous detection of five major opium alkaloids M.G. Carlin PhD 2015 Development and evaluation of an LC-ESI- MS method for the simultaneous detection of five major opium alkaloids Michelle Groves Carlin A thesis submitted in partial fulfilment of the requirements of the University of Northumbria at Newcastle for the degree of Doctor of Philosophy Research undertaken in the Department of Applied Sciences, Faculty of Health & Life Sciences August 2015 Abstract The aim of this work was to establish an analytical method for the simultaneous detection of five major opium alkaloids in poppy seeds by liquid chromatography-electrospray ionisation-mass spectrometry (LC- ESI-MS). Once opium alkaloids were detected in poppy seeds, toxicological studies were carried out to establish if these compounds were detected in oral fluid (OF) of participants who ingested muffins containing poppy seeds. It is known that the ingestion of poppy seeds has caused positive opiate drug test results and much work has been reported in the scientific literature in the last 20 years. Researchers in the field have investigated alternatives to differentiate between heroin administration and that of other opiate drugs versus poppy seed ingestion. Most of the work which has been carried out relates to establishing illicit heroin use by examining biological matrices for the presence of acetylcodeine, thebaine, papaverine, noscapine and their associated metabolites. The research methodology consisted of establishing an LC-ESI-MS method for the simultaneous detection of five major opium alkaloids (morphine, codeine, thebaine, papaverine and noscapine). A deuterated internal standard (morphine-d3) was used for the quantitation of alkaloids in harvested poppy seeds and oral fluid samples.
    [Show full text]
  • The Life Cycle of Sterling Drug, Inc.*
    22 Bull. Hist. Chem., VOLUME 25, Number 1 (2000) THE LIFE CYCLE OF STERLING DRUG, INC.* Joseph C. Collins and John R. Gwilt The foundations of Sterling Drug were laid by William partners were bought out. Weiss and Diebold realized E. Weiss and Albert H. Diebold, boyhood friends in that expansion required more product lines and that these Canton, Ohio. Weiss graduated from the Philadelphia would best be obtained by acquisition. This policy con- College of Pharmacy in 1896 and went to work in a tinued throughout the life of the organization, at least drug store in Sistersville, West Virginia. Diebold raised 130 companies being acquired, directly or indirectly, funding from his father’s company, Diebold Safe and Lock, and in 1901 the friends set up business together in Wheeling, WV. In fact, Sterling operated a plant in that town until 1962. The history of the Corporation can conveniently be divided into five periods: 1901-1917 The Neuralgyline Period 1917-1928 Sterling Products I 1928-1933 Drug Inc. 1933-1942 Sterling Products II 1942-1988 Sterling Drug, Inc. The Neuralgyline Period On May 4, 1901, Weiss and Diebold, with three local business men as partners, established the Neuralgyline Company with the sole purpose of manufacturing and Figure 1. Where it all began: in 1901 the selling a pain-relieving preparation which they called Neuralgyline Company occupied two upstairs rooms “Neuralgine.” There is now no company record of its in this house in Wheeling, WV. composition, but it seems to have been a mixture of ac- from 1902 through 1986. Ironically, the eventual fate etanilide, caffeine, and sodium salicylate.
    [Show full text]
  • I.G. Farben's Petro-Chemical Plant and Concentration Camp at Auschwitz Robert Simon Yavner Old Dominion University
    Old Dominion University ODU Digital Commons History Theses & Dissertations History Summer 1984 I.G. Farben's Petro-Chemical Plant and Concentration Camp at Auschwitz Robert Simon Yavner Old Dominion University Follow this and additional works at: https://digitalcommons.odu.edu/history_etds Part of the Economic History Commons, and the European History Commons Recommended Citation Yavner, Robert S.. "I.G. Farben's Petro-Chemical Plant and Concentration Camp at Auschwitz" (1984). Master of Arts (MA), thesis, History, Old Dominion University, DOI: 10.25777/7cqx-5d23 https://digitalcommons.odu.edu/history_etds/27 This Thesis is brought to you for free and open access by the History at ODU Digital Commons. It has been accepted for inclusion in History Theses & Dissertations by an authorized administrator of ODU Digital Commons. For more information, please contact [email protected]. 1.6. FARBEN'S PETRO-CHEMICAL PLANT AND CONCENTRATION CAMP AT AUSCHWITZ by Robert Simon Yavner B.A. May 1976, Gardner-Webb College A Thesis Submitted to the Faculty of Old Dominion University in Partial Fulfillment of the Requirements for the Degree of MASTER OF ARTS HISTORY OLD DOMINION UNIVERSITY August 1984 Approved by: )arw±n Bostick (Director) Reproduced with permission of the copyright owner. Further reproduction prohibited without permission. Copyright by Robert Simon Yavner 1984 All Rights Reserved Reproduced with permission of the copyright owner. Further reproduction prohibited without permission. ABSTRACT I.G. FARBEN’S PETRO-CHEMICAL PLANT AND CONCENTRATION CAMP AT AUSCHWITZ Robert Simon Yavner Old Dominion University, 1984 Director: Dr. Darwin Bostick This study examines the history of the petro­ chemical plant and concentration camp run by I.G.
    [Show full text]